|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
DNA differential display analysis (DD-PCR) was utilized to identify genes that are expressed in airway
epithelium and are relevant to airway inflammation; cytokine-mediated induction of gene expression and
inhibition of that induction by glucocorticoids were the criteria for selection. The IB3-1 cell line was cultured in the presence of tumor necrosis factor-
(TNF-
), dexamethasone, or dimethyl sulfoxide (DMSO)
as a control, and analyzed via DD-PCR and Northern blot analyses. With this approach, two TNF-
-
inducible and dexamethasone (DEX)-sensitive expressed sequence tags (EST8 and EST19) were identified. In IB3-1 cells, TNF-
increased messenger RNA (mRNA) expression of EST8 (34%, P
0.005) and
EST19 (41%, P
0.01), whereas dexamethasone reduced this expression to resting levels. This pattern of
mRNA expression was also observed in normal human bronchial epithelial cells (EST8: 21%, P
0.009;
EST19: 11%, P
0.02) and in the basophil leukemia cell line KU812 (EST8: 34%, P
0.01). Through
basic local alignment search tool (BLAST) analysis, it was determined that these ESTs exhibited significant homology with the monomeric G protein rhoC (EST8: 100% homology, P = 1.6 × 10
100) and the
UFO tyrosine kinase receptor (EST19: 86% homology, 5.3 × 10
28).
| |
Introduction |
|---|
|
|
|---|
The airway epithelium is composed of several cell types including ciliated, basal, and goblet cells, which are exposed
to a myriad of external stimuli. Airway epithelial cells
have classically been thought of as barrier cells that are involved in homeostasis and respond to a variety of environmental stimuli, resulting in the alteration of their cellular
functions, such as ion transport and movement of airway
secretions. Recent evidence, however, suggests that airway
epithelial cells may also act as effector cells in response to
noxious endogenous or exogenous stimuli; several studies have shown that they produce and secrete a variety of inflammatory mediators including lipid mediators (8, 14),
oxygen radicals (2, 17), tumor necrosis factor-
(TNF-
)
(10), granulocyte-macrophage colony-stimulating factor
(GM-CSF) (9), and interleukin-6 (IL-6) (4, 22), and chemokines such as IL-8 (4, 26), regulated on activation, normal
T-cell expressed and secreted (RANTES) (18, 35), and
others. The production of such inflammatory mediators implicates epithelial cells in the initiation and/or exacerbation of airway inflammatory diseases such as asthma and
cystic fibrosis.
At present, inhaled and intranasal steroids are among
the most efficacious treatments for airway inflammatory
diseases. However, the mechanisms by which glucocorticoids mediate their anti-inflammatory effects are not well
understood. Several studies have shown that glucocorticoids regulate the transcription of numerous genes involved in inflammation. Glucocorticoids may upregulate
the transcription of hormone-inducible genes through
binding of the activated glucocorticoid receptor (GR) to
specific DNA sequences termed glucocorticoid response
elements (GREs), located in the promoter region of the target genes (39). Alternatively, the activated GR may
bind to negative GREs (nGREs) (31) and/or interact with
transcription factors such as nuclear factor-
B (NF-
B)
(29) and activator protein-1 (AP-1) (15, 33, 41) to downregulate gene expression. In addition, glucocorticoids may
decrease the stability of specific mRNA molecules, thereby
modulating gene transcription (16). Although there is evidence for glucocorticoid-induced anti-inflammatory proteins, including lipocortin (13) and neutral endopeptidase (6), it is now appreciated that the ability of glucocorticoids to suppress the transcription of genes involved in inflammation may be their primary activity (38). Notable among
glucocorticoid-suppressed genes are those for collagenase
(15, 33, 41), inducible nitric oxide synthase (11, 28), cyclooxygenase-2, (25), and most cytokine and chemokine
genes (32).
DNA differential display analysis (DD-PCR), developed by Liang and Pardee (23), is a powerful new technology that permits the identification and cloning of differentially expressed genes on a global scale. This method involves the reverse transcription of mRNAs with oligo-dT primers anchored to the 5' end of the poly(A) tail, followed by amplification in the presence of random primers, thereby generating double-stranded complementary DNA (cDNA) products of varying lengths. By changing primer combinations, up to 15,000 individual mRNA species from a mammalian cell may by visualized (23). DD-PCR has several advantages over existing methods, including subtractive hybridization (23); DD-PCR is very sensitive, requiring small amounts of total RNA for the visualization of expressed mRNA species in a mammalian cell line; and it is highly reproducible, with approximately 95% of the bands reproduced from one run to another. Moreover, this method allows simultaneous analysis of multiple RNA samples per run, thereby revealing genes unique to a given cell type or cellular process.
In the present study, DD-PCR was utilized to identify
genes expressed in human airway epithelial cells that are
relevant to airway inflammation and glucocorticoid action.
In particular, genes induced in airway epithelial cells as a
result of cytokine stimulation, and for which such induced
expression was inhibited by glucocorticoids, were targeted.
Using this approach, two candidate TNF-
-inducible and
dexamethasone (DEX)-sensitive gene products were identified, including candidates with significant homology to
the rhoC small monomeric G protein and the UFO receptor (a novel tyrosine kinase receptor). Putative roles for
rhoC and the UFO receptor in airway inflammation are
discussed.
| |
Materials and Methods |
|---|
|
|
|---|
Cell Culture and RNA Isolation
The following human cell types were employed: the airway
epithelial cell lines IB3-1 (a gift from Dr. Pam Zeitlin,
Johns Hopkins University, Baltimore, MD) (42) and
BEAS2B (30); cultured normal bronchial epithelial cells
(NHBE; Clonetics Corp., San Diego, CA) (20); cultured
synovial fibroblasts (a gift from Dr. Joan Bathon, Johns
Hopkins University) (3); cultured human umbilical vein
endothelial cells (HUVEC) (5); the T-lymphocyte cell
line Jurkat (40); the monocyte cell line U937 (36); and the
basophil leukemia cell line KU812 (12). All airway epithelial cells, including IB3-1, BEAS2B, and NHBE, were
grown in Vitrogen 100 (Collagen Corp., Palo Alto, CA)-
coated-flasks. IB3-1 and BEAS2B were cultured in LHC-8
(Biofluids, Inc., Rockville, MD) containing 5% fetal calf serum (FCS), 1% penicillin-streptomycin, and 0.2% fungizone. NHBE were cultured in serum-free bronchial epithelial cell growth medium (BEGM) (supplemented
[LHC-9]; complete ingredients available from Clonetics
Corp.). All other cell types were cultured in RPMI (Paragon, Inc., Baltimore, MD) containing 10% FCS, 1% penicillin-streptomycin, 0.2% fungizone, and 1% glutamine. Each cell type, adherent cells at 80% confluence and nonadherent cells at 106 cells/ml, was cultured in the presence
of TNF-
(100 ng/ml; R&D Systems, Minneapolis, MN)
with or without the glucocorticoid DEX (1 µM; Sigma Cemical Co., St. Louis, MO) or an equivalent amount of the
carrier control dimethyl sulfoxide (DMSO) (Sigma Chemical Co.) for 20 h at 37°C. Following culture, cells were lysed
and total RNA was isolated via the RNAzol-B method
(Tel-Test Inc., Friendswood, TX) (7).
DNA Differential Display Analysis
Total RNA was treated with deoxyribonuclease I (DNase
I) (1 U/µg RNA; Gibco BRL, Grand Island, NY) for 15 min at room temperature; the reaction was stopped with
addition of 20 mM ethylenodiamine tetraacetic acid
(EDTA) and subsequent heating to 65°C for 10 min.
DNAse-treated RNA samples (0.2 µg/reaction) were then
reverse transcribed in the presence of the oligo-dT primer
T12MN (1 µM; GenHunter Corp., Brookline, MA) (23)
where M represents a mixture of the base G, A, or C, and
N represents the base G, A, T, or C, Moloney murine leukemia virus (MMLV) reverse transcriptase (100 U/reaction; GenHunter, Inc.); and deoxynucleotide triphosphates (dNTPs) (20 mM; GenHunter Corp.). Reactions were
incubated at 37°C for 1 h and then at 95°C for 5 min to inactivate the enzyme. Resulting cDNA products (2 µl/reaction) were amplified via PCR (Hybaid automatic thermocycler; Labnet, Woodbridge, NJ) in the presence of two
different 10-mer "random" primers (GenHunter Corp.) that bind randomly to DNA. Amplification reactions contained AmpliTaq polymerase (1 U/reaction; Perkin-Elmer
Corp., Norwalk, CT), dNTPs (2 µM; GenHunter Corp.),
AP primers 1 to 10 (0.2 µM; GenHunter Corp.), and
[
-35S]deoxyadenosine triphosphate ([
-35S]-dATP) (1,200 Ci/mmole; New England Nuclear/Dupont, Inc., Boston, MA). Amplification reactions were cycled at 94°C for 30 s,
40°C for 2 min, and 72°C for 30 s for 40 cycles; reactions
then underwent a final extension at 72°C for 5 min. All reactions were performed in duplicate. PCR products were
visualized on a 6% DNA sequencing gel, and selected
bands were precipitated. Briefly, bands were cut from the
gel, soaked in 100 µl of distilled water (dH2O) for 15 min
at room temperature, and then heated to 100°C for 15 min. DNA was precipitated in the presence of sodium acetate
(60 µM), glycogen (100 µg/ml; GenHunter Corp.), and
100% ethanol; samples were set on dry ice for 30 min and
DNA was then pelleted and washed with 85% ethanol.
Each sample was reamplified with the respective primer
pair as described earlier.
T-A Cloning
Amplified cDNA products (ESTs) were electrophoresed in a 1% agarose gel and purified with the QIAquick Gel Extraction Kit (Qiagen Corp., Chatsworth, CA). cDNA fragments were then cloned into the pGEM-T vector using the pGEM T-A Cloning Kit (Promega Corp., Madison, WI). Briefly, cDNA fragments were ligated into the pGEM-T vector with T4 DNA ligase (1 U/reaction) at an insert-to-vector ratio of 10:1. JM109 cells (Promega Corp.) were transformed with the plasmid and plated on Luria broth (LB)-agar containing ampicillin (100 µg/ml; Sigma Chemical Co.), X-gal (20 µg/ml; Sigma Chemical Co.), and isopropylthiogalactopyranoside (IPTG) (0.1 mM; Sigma Chemical Co.). Positive EST-pGEM clones were selected via blue-white screening and expanded in ampicillin-containing (100 µg/ml) LB; plasmid DNA was isolated with the Perfect Prep Kit (5 Prime-3 Prime, Inc., Boulder, CO).
False-positive Analysis
Ten positive pGEM clones for each EST were prepared for dideoxy sequencing of one nucleotide base, using the DNA Sequencing Kit with Sequenase (United States Biochemical-Amersham Co., Arlington Heights, IL), and were analyzed on a 6% DNA sequencing gel. Sequences were then compared, and the majority of identical sequences was considered to be the true-positive EST.
Northern Blot Analysis
Cells were cultured as described earlier and poly-A+ RNA
was isolated with the Micro-Fast Track Kit (Invitrogen,
San Diego, CA). Two micrograms of poly-A+ RNA were
electrophoresed in a 1% agarose gel and transferred to a
nylon filter membrane (GeneScreen Plus; New England
Nuclear-Dupont, Inc.). The RNA was then hybridized
with a [
-32P]dATP-labeled EST fragment, utilized as a
cDNA probe (5 × 105 cpm/ml hybridization buffer; Random Label Kit, Gibco BRL Life Tech., Inc.). The hybridization buffer contained 50% formamide, 2X 1,4-piperazinediethanesulfonic acid (PIPES), 0.5% sodium dodecyl sulfate (SDS) and 100 µg/ml of sheared, heat-denatured
salmon sperm DNA (Sigma Chemical Co.). Autoradiograms of the filter were analyzed via densitometry.
Automated DNA Sequencing and BLAST Analysis
The cloned EST fragments were sequenced on both strands, using an automated ABI 373A sequencer according to the manufacturer's procedures and chemistry. Alignments were done with computer software designed by the Genetics Computer Group (University of Wisconsin, Madison, WI).
| |
Results |
|---|
|
|
|---|
DNA Differential Display Analysis
To identify novel genes associated with airway inflammation, the IB3-1 cell line, an airway epithelial cell line derived from a cystic fibrosis patient and immortalized with
the adenovirus 12-SV40 viral construct (42), was cultured
in the presence of TNF-
(100 ng/ml) with or without
DEX (1 µM) or an equivalent amount of the carrier control DMSO for 20 h at 37°C; all cultures were done in
duplicate. TNF-
was chosen as a stimulus for two reasons:
(1) TNF-
is a cytokine associated with airway inflammation (21); and (2) TNF-
-induced signals can be almost
completely suppressed by DEX (35). These studies were
performed with cells treated for 20 h, since a number of
TNF-
-inducible, DEX-sensitive molecules, such as the
chemokine RANTES, are expressed maximally at this duration in airway epithelial cells (35). Following culture,
total RNA was isolated from the IB3-1 cells, treated with
DNase (1 U/reaction) to remove contaminating DNA, and
then analyzed with DNA differential display analysis, as
described in MATERIALS AND METHODS, for mRNAs that
were differentially expressed in treated and untreated cells
(Figure 1).
|
False-positive and Northern Blot Analyses
Expressed sequence tags (ESTs) representing mRNAs
that were upregulated in the presence of TNF-
alone and
eliminated in the presence of TNF-
and DEX were
eluted from the gel and reamplified via PCR with the respective 10-mer primer pairs. With this approach, 19 ESTs
were identified and successfully reamplified. Following reamplification, ESTs were subcloned into the pGEM-T
vector, and positive clones were selected and expanded in
order to obtain large amounts of plasmid DNA in preparation for false-positive analysis. Briefly, 10 positive pGEM
clones for each EST were prepared for dideoxy sequencing
of one nucleotide base, using the DNA Sequencing Kit
with Sequenase (United States Biochemical-Amersham
Co.), and were analyzed on a 6% DNA sequencing gel
(data not shown). Sequences were then compared; the majority of identical sequences was considered to be the true-positive EST.
The regulation of the ESTs by cytokines and glucocorticoids was confirmed through Northern blot analysis. This
was essential, as it established that a given candidate gene
truly fit the requirements of cytokine inducibility and glucocorticoid sensitivity while at the same time indicating
the size of the EST mRNA and its relative levels of expression. To this end, IB3-1 cells were cultured in the presence of TNF-
, DEX, or an equivalent amount of DMSO
for 20 h at 37°C, as described previously. Following culture, poly-A+ RNA was isolated from these cells and prepared for Northern blot analysis. Poly-A+ RNA comprises
1 to 2% of total RNA; therefore, the Northern blot analysis of microgram quantities of poly-A+ RNA, rather than
total RNA, increases the sensitivity of this assay by at least
10-fold. Northern blots were probed with ESTs that had
been amplified via PCR from true-positive EST-pGEM
clones and labeled randomly. Although 19 ESTs were
identified originally via DD-PCR, only EST8 and EST19
yielded the expected pattern of expression by Northern
blot analysis; of the remaining ESTs, six were expressed in
the presence and absence of TNF-
and/or DEX and 11 were not inducible by TNF-
. TNF-
increased the level of mRNA expression of EST8 (34%, P
0.005, n = 5)
and EST19 (41%, P
0.01, n = 5), whereas DEX reduced
this expression to resting levels or below (Figure 2). To determine the time point of maximal EST8 and EST19
mRNA expression, IB3-1 cells were cultured in the presence of TNF-
, DEX, or DMSO, as described previously,
for 30 min and 1, 2, 6, 12, and 20 h at 37°C; poly-A+ RNA
was isolated and analyzed via Northern blot analysis with the respective EST probes. In this assay, 20 h after culture
was the time of maximum expression for both EST8 and
EST19 in IB3-1 cells (n = 3, data not shown).
|
Again using Northern blot analysis, the expression of
EST8 and EST19 was examined in various cell types such
as endothelial cells, lymphocytes, monocytes, fibroblasts,
and basophils, as well as other airway epithelial cells, including BEAS2B and NHBE cells. All cells were treated
with TNF-
(100 ng/ml), DEX (1 µM), or DMSO for 20 h
at 37°C, as described previously, and prepared for poly-A+
RNA isolation and Northern blot analysis. NHBE cells
yielded the expected pattern of both EST8 (21%, P
0.009, n = 3) and EST19 (11%, P
0.02, n = 3) expression (Figure 3), whereas KU812 gave the expected pattern
of EST8 expression (34%, P
0.01, n = 3) only (Figure
4). Although the remaining cell types expressed both
EST8 and EST19, TNF-
did not induce the expression of
these ESTs in the other cell types tested (n = 3 for each;
data not shown).
|
|
DNA Sequencing and BLAST Analyses
Following Northern blot analysis, EST8 and EST19 were
sequenced on both strands with an automated ABI 373A
sequencer. DNA sequences were then compared with
public sequence databases, including GenBank and
EMBL, using basic local alignment search tool (BLAST) algorithms (1), to determine whether any of the ESTs
shared homology at the nucleotide level with previously
identified genes. With this approach, it was determined
that EST8 has virtual identity to the small, monomeric G
protein rhoC (100% homology, P = 1.6 × 10
100, Figure
5a), which appears to be involved in focal adhesion and cytoskeletal reorganization, (27, 37), whereas EST19 exhibited homology with the human UFO tyrosine kinase receptor (86% homology, P = 5.3 × 10
28, Figure 5b) (34).
|
| |
Discussion |
|---|
|
|
|---|
In order to uncover new information about the mechanisms of airway inflammation and glucocorticoid action in
humans, we utilized DD-PCR to identify genes in human
airway epithelial cells that are relevant to inflammatory
disease and glucocorticoid action. In particular, genes that
are expressed in airway epithelial cells as a result of cytokine stimulation, and for which such induced expression is
inhibited by glucocorticoids, were targeted. Through this
analysis, two ESTs, EST8 and EST19, were identified, subcloned, and sequenced from the airway epithelial cell line
IB3-1. EST8 and EST19 displayed the expected pattern of
mRNA expression in IB3-1 cells as detected via Northern
blot analysis: TNF-
increased the level of mRNA expression for EST8 (34%, P
0.005) and EST19 (41%, P
0.01), whereas DEX reduced this expression to the resting level (Figure 2). This same pattern of EST8 (21%, P
0.009) and EST19 (11%, P
0.02) mRNA expression was
observed in TNF-
/DEX-treated normal human bronchial
epithelial cells (Figure 3), indicating the potential physiologic relevance of these two ESTs. In addition, TNF-
increased the expression of EST8 (34%, P
0.01) but not that of EST19 in the basophil leukemia cell line KU812
(Figure 4). This pattern of expression was not observed in
other cell types tested, including human endothelial cells,
synovial fibroblasts, lymphocytes, and monocytes, although
each expressed EST8 and EST19 at the basal level. Moreover, TNF-
did not induce EST8 and EST19 expression
over basal levels in other airway epithelial cells including
BEAS2B. Such differential expression of EST8 and
EST19 among cell types may be the result of differences in
culture conditions, lineage, or levels of TNF expression on
the cell surface. In addition, the IB3-1 and BEAS2B cell
lines may differ with respect to stage of differentiation
and/or epithelial cell origin; IB3-1 cells do not form tight
junctions (E. M. Schwiebert, unpublished observations), a
quality indicative of an undifferentiated phenotype, and
appear to be basal cell-like in morphology.
At present, it is unclear why the expression of all TNF-
-inducible, DEX-sensitive ESTs identified via DD-PCR
was not confirmed by Northern blot analysis. Although
DD-PCR is a powerful technique, there are potential
problems with this method. First, false-positive ESTs
(those bands that do not represent authentic mRNAs) may
be detected (23). In order to circumvent this problem, the
following approaches were taken in this study: (1) all samples for DD-PCR were run in duplicate in order to insure
that the banding pattern was reproducible; (2) total RNA
samples were treated with ribonuclease (RNAse)-free
DNAse I in order to remove contaminating DNA species that might have competed for reagents during amplification; and (3) false-positive ESTs that migrated at the same
position during electrophoresis as true-positive ESTs, and
might therefore have eluted simultaneously, were identified via partial dideoxy sequencing analysis of EST-pGEM
clones. Since only one EST fragment may be inserted into
one molecule of pGEM vector during a ligation, multiple positive clones from an EST-pGEM cloning event may
represent several different EST species. To determine the
true-positive EST, 10 EST-pGEM clones were partially sequenced and the sequences compared; the majority of
identical sequences was considered to be the true-positive EST. Second, certain combinations of primers may generate ESTs that are located in the 3' end of an expressed
gene, and may therefore represent untranslated sequences,
making homology analysis difficult. To decrease this possibility, cDNA products were amplified with pairs of "random" 10-mer primers instead of with a single "random" primer and the respective oligo-dT primer for amplification as described in the original Liang and Pardee protocol
(23); the "random" 10-mer primer combination permitted
the discovery of ESTs that had sizable open reading
frames, many with homology to known genes. Third, rare
mRNAs may not be visualized. Despite the high sensitivity
of DD-PCR, it may not detect mRNAs that exist at less
than 50 copies per cell (23). Taken together, these reasons
may also explain why the expression of previously identified genes known to be upregulated by TNF-
in airway
epithelial cells, such as RANTES (18, 35) and IL-8 (22),
was not detected with DD-PCR. Interestingly, recent
work has shown that the IB3-1 cell line expresses low levels of some TNF-
-inducible genes, including RANTES,
but not others, such as IL-8, as compared with other airway epithelial cell lines (L. M. Schwiebert, unpublished observations). It is conceivable that modifications to DD-
PCR, such as utilizing higher annealing temperatures during the initial cycles of the PCR amplification step together with longer random primers (15- to 20-mers), may
further decrease the generation of false positives and enhance the detection of true TNF-
-inducible genes.
With BLAST analysis, it was determined that EST8 and
EST19 displayed significant homology with rhoC and the
human UFO tyrosine kinase receptor (UFO-R), respectively
(Figure 5). Although TNF-
treatment of the IB3-1 airway
epithelial cell line induced a modest increase in the expression of mRNA for each of these ESTs, it is possible that
such an increase results in a significant enhancement of rhoC
and/or UFO-R protein levels and/or function. RhoC is a member of the ras superfamily/rho subfamily of small monomeric guanosine triposphate (GTP)-binding proteins,
which also includes rhoA, rhoB, rac, and cdc42. The rho
subfamily has been shown to regulate assembly of focal
adhesion complexes and actin stress fiber formation in fibroblasts (27, 37). Recently, Laudanna and colleagues reported that rhoA is also involved in chemoattractant-mediated adhesion of leukocytes (19). Specifically, their study
demonstrated that inactivation of rho by the rho-specific
inhibitor Clostridium botulinum C3 exoenzyme blocked
IL-8-induced lymphocyte
4
1 adhesion to vascular cell
adhesion molecule-1 (VCAM-1) and formyl-methionylleucylphenylalanine (fMLP)-induced neutrophil
2-integrin
adhesion to fibrinogen (19). Given this, rhoC may play a
similar role in airway epithelium (i.e., rhoC may mediate
focal adhesion formation between cells and/or signal transduction through integrins or other receptors expressed on
the airway epithelial cell surface). Similarly, UFO-R, an
orphan tyrosine kinase receptor expressed in a variety of
different cell types (34), may also play a role in signaling
the airway epithelial cell during an inflammatory response,
possibly resulting in the production and secretion of inflammatory mediators. The human UFO-R contains two
immunoglobulinlike and two fibronectin type III repeats
in the extracellular portion, a single transmembrane region,
and putative tyrosine kinase activity in the intracellular domain (34).
The findings discussed herein indicate the potential usefulness of DNA differential display in identifying genes that may be associated with airway inflammation. Ultimately, it is hoped that information gained from this approach will be important in understanding the cellular and molecular mechanisms of airway inflammatory responses and glucocorticoid actions.
| |
Footnotes |
|---|
Address correspondence to: Dr. Robert P. Schleimer, Johns Hopkins Asthma and Allergy Center, Room 3A.62, 5501 Hopkins Bayview Circle, Baltimore, MD 21224.
(Received in original form September 12, 1996 and in revised form December 2, 1996).
Acknowledgments: The authors would like to thank Drs. Ted Torphy and Christine Debouck of SmithKline Beecham Pharmaceuticals and the members of the Schlochneck Laboratory for their continued support. This work was supported by grants from the American Lung Association (RT-019-N) to Dr. Schwiebert and from the National Institutes of Health (1 PO1 HL49545-03, 5UO1 AI31867-05) to Dr. Schleimer.
Abbreviations
AP-1, activator protein-1;
BLAST, basic local alignment search
tool;
DD-PCR, differential display-polymerase chain reaction;
fMLP, formyl methionylleucylphenylalanine;
IPTG, isopropyl thiogalactopyranoside;
NF-
B, nuclear factor-
B;
VCAM-1, vascular cell adhesion molecule-1.
| |
References |
|---|
|
|
|---|
1. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215: 403-410 [Medline].
2.
Barnes, P. J., and
M. G. Belvisi.
1993.
Nitric oxide and lung disease.
Thorax
48:
1034-1043
3. Bathon, J. M., D. Proud, S. Mizutani, and P. E. Ward. 1992. Cultured human synovial fibroblasts rapidly metabolize kinins and neuropeptides. J. Clin. Invest. 90: 981-991 .
4. Bedard, M., C. D. McClure, N. L. Schiller, C. Francoeur, A. Cantin, and M. Denis. 1993. Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 9: 455-462 .
5. Bochner, B. S., D. A. Klunk, S. A. Sterbinsky, R. L. Coffman, and R. P. Schleimer. 1995. Interleukin-13 selectively induces vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. J. Immunol. 154: 799-803 [Abstract].
6.
Borson, D. B., and
D. C. Gruenert.
1991.
Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells.
Am. J. Physiol.
260:
L83-L89
7. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159 [Medline].
8. Churchill, L., F. H. Chilton, J. H. Resau, R. Bascom, W. C. Hubbard, and D. Proud. 1989. Cyclooxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells. Am. Rev. Respir. Dis. 140: 449-459 [Medline].
9. Churchill, L., B. Friedman, R. P. Schleimer, and D. Proud. 1992. Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells. Immunology 75: 189-195 [Medline].
10. Devalia, J. L., A. M. Campbell, R. J. Sapsford, C. Ruszak, D. Quint, P. Godard, J. Bousquet, and R. J. Davies. 1993. Effect of nitrogen dioxide on synthesis of inflammatory cytokines by human bronchial epithelial cells in vitro. Am. J. Respir. Cell Mol. Biol. 9: 271-279 .
11. Di Rosa, M., M. Radomski, R. Carnuccio, and S. Moncada. 1990. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem. Biophys. Res. Commun. 172: 1246-1252 [Medline].
12. Fischoff, S. A., K. Kishi, W. R. Benjamin, R. M. Rossi, M. C. Hoessly, J. A. Hoxie, C. Seals, L. Anderson, T. Ishizaka, and J. Hakimi. 1987. Induction of differentiation of the human leukemia cell line, KU812. Leuk. Res. 11: 1105-1113 [Medline].
13. Goulding, N. J., J. L. Godolphin, P. R. Sharland, S. H. Peers, M. Sampson, P. J. Maddison, and R. J. Flower. 1990. Anti-inflammatory lipocortin 1 production by peripheral leucocytes in response to hydrocortisone. Lancet 335: 1416-1418 [Medline].
14.
Hunter, J. A.,
W. E. Finkbeiner,
J. A. Nadel,
E. J. Goetzl, and
M. J. Holtzman.
1985.
Predominant generation of 15-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea.
Proc. Natl. Acad. Sci.
USA
82:
4633-4677
15. Jonat, C., H. J. Rahmsdorf, K.-K. Park, A. C. B. Cato, S. Gebel, H. Ponta, and P. Herrlich. 1990. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62: 1189-1204 [Medline].
16. Kern, J. A., R. J. Lamb, J. C. Reed, R. P. Daniele, and P. C. Nowell. 1988. Dexamethasone inhibition of interleukin-1 beta production by human monocytes. J. Clin. Invest. 81: 237-244 .
17. Kobzik, L., J. Drazen, and D. Bredt. 1993. Nitric oxide synthase (NOS) in the lung: immunologic and histochemical localization in human and rat tissue. Am. Rev. Respir. Dis. 147: A515 . (Abstr.) .
18. Kwon, O. J., P. J. Jose, R. A. Robbins, T. J. Schall, T. J. Williams, and P. J. Barnes. 1995. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am. J. Respir. Cell Mol. Biol. 12: 488-496 [Abstract].
19. Laudanna, C., J. J. Campbell, and E. C. Butcher. 1996. Role of rho in chemoattractant-activated leukocyte adhesion through integrins. Science 271: 981-983 [Abstract].
20. Lechner, J., A. Haugen, I. A. McClendon, and W. Pettis. 1982. Clonal growth of normal adult human bronchial epithelial cells in a serum-free medium. In Vitro 18: 633-641 [Medline].
21. Levine, S. J.. 1995. Bronchial epithelial cell-cytokine interactions in airway inflammation. J. Invest. Med. 43: 241-249 [Medline].
22.
Levine, S. J.,
P. Larivee,
C. Logun,
C. W. Angus, and
J. H. Shelhamer.
1993.
Corticosteroids differentially regulate secretion of IL-6, IL-8, and G-CSF
by a human bronchial epithelial cell line.
Am. J. Physiol.
265:
L360-L368
23.
Liang, P.,
L. Averboukh, and
A. B. Pardee.
1993.
Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and
optimization.
Nucleic Acids Res.
21:
3269-3275
24. Lieber, M., B. Smith, A. Szakal, W. Nelson-Rees, and G. Todaro. 1976. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int. J. Cancer 17: 62-70 [Medline].
25. Mitchell, J. A., M. G. Belvisi, P. Akarasereemom, R. A. Robbins, O. J. Kwon, J. Croxtall, P. J. Barnes, and J. R. Vane. 1994. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br. J. Pharmacol. 113: 1008-1014 [Medline].
26.
Nakamura, H.,
K. Yoshimura,
H. Jaffe, and
R. G. Crystal.
1991.
Interleukin-8 gene expression in human bronchial epithelial cells.
J. Biol. Chem.
266:
19611-19618
27. Nobes, C., and A. Hall. 1994. Regulation and function of the Rho subfamily of small GTPases. Curr. Opin. Gen. Dev. 4: 77-81 [Medline].
28.
Radomski, M. W.,
R. M. J. Palmer, and
S. Moncada.
1990.
Glucocorticoids inhibit the expression of an inducible, but not the constitutive nitric oxide
synthase in vascular endothelial cells.
Proc. Natl. Acad. Sci. USA
87:
10043-10049
29.
Ray, A., and
K. E. Prefontaine.
1994.
Physical association and functional
antagonism between the p65 subunit of transcription factor NF-kappaB
and the glucocorticoid receptor.
Proc. Natl. Acad. Sci. USA
91:
752-756
30.
Reddel, R. R.,
Y. Ke,
B. I. Gerwin,
M. G. McMenamin,
J. F. Lechner,
R. T. Su,
D. E. Brash,
P.-B. Park,
J. S. Rhim, and
C. C. Harris.
1988.
Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV4- hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes.
Cancer
Res.
48:
1904-1909
31.
Sakai, D. D.,
S. Helms,
J. Carlstedt-Duke,
J.-A. Gustafsson,
F. M. Rottman, and
K. R. Yamamoto.
1988.
Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene.
Genes Dev.
2:
1144-1154
32. Schwiebert, L. M., C. Stellato, L. A. Beck, B. S. Bochner, and R. P. Schleimer. 1996. Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. J. Allergy Clin. Immunol. 97: 143-147 [Medline].
33. Schule, R., P. Rangarajan, S. Kliewer, L. J. Ranson, J. Bolado, N. Yang, I. M. Verma, and R. M. Evans. 1990. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62: 1217-1226 [Medline].
34. Schulz, A. S., L. Schleithoff, M. Faust, C. R. Bartram, and J. W. G. Janssen. 1993. The genomic structure of the human UFO receptor. Oncogene 8: 509-513 [Medline].
35. Stellato, C., L. A. Beck, G. A. Gorgone, D. Proud, T. J. Schall, S. J. Ono, L. M. Lichtenstein, and R. P. Schleimer. 1995. Expression of the chemokine RANTES by a human bronchial epithelial cell line: modulation by cytokines and glucocorticoids. J. Immunol. 155: 410-418 [Abstract].
36. Sundstrom, C., and K. Nilsson. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17: 565-577 [Medline].
37. Takai, Y., T. Saski, K. Tanaka, and H. Nakanishi. 1995. Rho as a regulator of the cytoskeleton. Trends Biol. Sci. 20: 227-231 .
38. Taylor, I. K., and R. J. Shaw. 1993. The mechanism of action of corticosteroids in asthma. Respir. Med. 87: 261-277 [Medline].
39. Tsai, M.-J., and B. W. O'Malley. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63: 451-486 [Medline].
40. Weiss, A., R. L. Wiskocil, and J. D. Stobo. 1984. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL-2 production reflects events occurring at a pretranslational level. J. Immunol. 133: 123-128 [Abstract].
41. Yang-Yen, H.-F., J.-C. Chambard, Y.-L. Sun, T. Smeal, T. J. Schmidt, J. Drouin, and M. Karin. 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62: 1205-1215 [Medline].
42. Zeitlin, P. L., L. Lu, J. Rhim, G. Cutting, G. Stretten, K. A. Keiffer, R. Craig, and W. B. Guggino. 1991. A cystic fibrosis bronchial epithelial cell line: immortalization by adenovirus 12-SV40 infection. Am. J. Respir. Cell Mol. Biol. 4: 313-317 .
This article has been cited by other articles:
![]() |
J. Sturtevant Applications of Differential-Display Reverse Transcription-PCR to Molecular Pathogenesis and Medical Mycology Clin. Microbiol. Rev., July 1, 2000; 13(3): 408 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
D E Davies, R Djukanovic, and S T Holgate Application of functional genomics to study of inflammatory airways disease Thorax, January 1, 1999; 54(1): 79 - 81. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |